Catophos 100 mg/ml + 0.05 mg/ml solution for injection for horses, cattle, dogs and cats

Valsts: Īrija

Valoda: angļu

Klimata pārmaiņas: HPRA (Health Products Regulatory Authority)

Nopērc to tagad

Produkta apraksts Produkta apraksts (SPC)
29-11-2023
DSU DSU (DSU)
29-11-2023

Aktīvā sastāvdaļa:

Cyanocobalamin; Butaphosphan (Butafosfan)

Pieejams no:

CP-Pharma Handelsgesellschaft mbH

ATĶ kods:

QA12CX99

SNN (starptautisko nepatentēto nosaukumu):

Cyanocobalamin; Butaphosphan (Butafosfan)

Zāļu forma:

Solution for injection

Receptes veids:

POM: Prescription Only Medicine as defined in relevant national legislation

Ārstniecības joma:

other mineral products, combinations

Autorizācija datums:

2023-09-01

Produkta apraksts

                                1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Catophos 100 mg/ml + 0.05 mg/ml solution for injection for horses,
cattle, dogs and cats
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains
ACTIVE SUBSTANCES:
Butafosfan:
100.00 mg
Cyanocobalamin (vitamin B12):
0.05 mg
EXCIPIENT:
Benzyl alcohol (E 1519)
20.00 mg
For the full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
_ _
Solution for injection.
Clear, pink solution.
_ _
_ _
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle, horses, dogs and cats.
_ _
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
_ _
As supportive treatment of metabolic or reproductive disorders, when
supplementation of
phosphorous and cyanocobalamin is needed.
In case
_ _
of peri-parturient metabolic disorders, tetany and paresis (milk
fever), the product should
be administered in addition to magnesium and calcium, respectively.
Supporting
muscle
function
in
the
presence
of
deficiencies
of
phosphorous
and/or
cyanocobalamin.
4.3
CONTRAINDICATIONS
_ _
Do not use in cases of hypersensitivity to the active substances or to
any of the excipients.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
_ _
It is recommended to determine the cause(s) of the metabolic or
reproductive disorders to define
the most appropriate measures of prevention and treatment and the need
for a therapy with
supplemental phosphorus and vitamin B
12
.
_ _
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Due to a deficiency in glucuronidating metabolic pathways in cats,
which are involved in
benzyl alcohol metabolism, this veterinary medicinal product should be
used with caution and
the recommended dose should be strictly observed in this species.
_ _
Special precautions to be taken by the person administering the
veterinary medicinal product to
animals
This veterinary medicinal product contains benzyl alcohol which may
cause hypersensitivity
(allergic) reactions. People with known hypersensitivity to benzyl
alcohol should avoid contact
with the veterinary medicinal product.
This prod
                                
                                Izlasiet visu dokumentu
                                
                            

Meklēt brīdinājumus, kas saistīti ar šo produktu